MENU
AARD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Aardvark Therapeutics (AARD) Earnings Date & Reports
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases... Show more
A.I. Advisor
published Earnings
AARD is expected to report earnings to fall 12.12% to -87 cents per share on August 19
Q2'26
Est.
$-0.87
Q1'26
Missed
by $0.22
Q4'25
Missed
by $0.01
Q3'25
Beat
by $0.02
Q2'25
Beat
by $0.04
The last earnings report on May 07 showed earnings per share of -99 cents, missing the estimate of -76 cents. With 45.82K shares outstanding, the current market capitalization sits at 89.01M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information